TrialClinical and translational science2019

Exposure-Response Analysis of Overall Survival for Tremelimumab in Unresectable Malignant Mesothelioma: The Confounding Effect of Disease Status.

Paul Baverel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.